$2.58
0.083.20%
At close: -
$2.58
0.000.00%
After Hours: 4:00 PM EDT
TScan Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of TScan Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-0.25 | $-0.29 | 13.8 % |
Q2 | 2024-08-12 | $-0.28 | $-0.28 | 0.00 % |
Q1 | 2024-05-13 | $-0.32 | $-0.25 | -28.0 % |
Q4 | 2024-03-06 | $-0.21 | $-0.29 | 27.6 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $1.05M | $1.06M | -1.04 % |
Q2 | 2024-08-12 | $536.00K | $2.42M | -77.8 % |
Q1 | 2024-05-13 | $566.00K | $3.97M | -85.7 % |
Q4 | 2024-03-06 | $7.21M | $3.34M | 115.9 % |
TScan Therapeutics (TCRX) is scheduled to report earnings on March 5, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.25, which beat the estimate of $-0.29.
The Actual Revenue was $1M, which missed the estimate of $1.1M.
Browse earnings estimates, EPS, and revenue on all stocks.